Bioptimus, the pioneering AI foundation model company, announced that it has reached a significant funding milestone of $76 million. This total includes a $41...
Mission Bio, a leader in single-cell multiomics solutions for precision medicine, announced the release of data from scientists at Genentech’s Analytical Development Group, showcasing...
Small molecule drug discovery acceleration experts and DNA-encoded library (DEL) technology pioneers X-Chem, Inc. welcomes Paul Davie as Chief Business Officer. He will lead global business development,...
QIAGEN and Myriad Genetics announced they will develop a globally distributable kit-based test for analyzing Homologous Recombination Deficiency (HRD) status. This next-generation sequencing (NGS)...
Sangamo Therapeutics, Inc. a genomic medicines company, presented pre-clinical data showcasing its novel next-generation integrase technology engineered to enable large-scale genome editing. Building on...
